HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Wellness Market Deals: Unilever Tries On SmartyPants, Kind Cooks Up Nature’s Bakery Deal

Executive Summary

Unilever North America agrees SmartyPant, founded in 2011 to create a comprehensive supplement made from premium ingredients to support the wellbeing needs of children and adults. Kind, fully owned by Mars, has an agreement to acquire family-owned Nature's Bakery which offers snacks including fig bars and other soft-baked foods.

You may also be interested in...



Unilever Stepping Up Pricing To Offset Rising Costs While New Businesses Continue To Fuel Growth

“We are still managing in COVID times,” says CEO Alan Jope during Unilever’s 22 July call to discuss fiscal 2021 first-half results.

Unilever Gets Portfolio In Order While Riding Prestige Beauty, Functional Nutrition Growth

Unilever’s prestige beauty business, bulked up by acquisitions over the past five years, achieved 21% underlying sales growth in the FY 2021 first quarter. The firm has formed a new business unit, Elida Beauty, to house a number of smaller, non-core beauty and personal-care brands accounting for around 600m in revenues following talk of possible divestitures.

Unilever Adds Alpha Brain Supplement Maker In Latest Wellness, Nutrition Portfolio Expansion

Unilever North America announces plans to acquire Onnit Labs, maker of a line of brain health, fitness and wellness supplements. Onnit has a large following online, attracting 1m visitors to its digital platform per month. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150762

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel